2022
DOI: 10.1007/s00259-022-06047-6
|View full text |Cite
|
Sign up to set email alerts
|

Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 38 publications
0
0
0
Order By: Relevance
“…Of these patients, 5 patients (6.94%) had pCR and 19 patients (26.39%) had MRD after NCHT. Furthermore, multivariate logistic analysis revealed that the post-NCHT maximum standardized uptake value (SUVmax) of the primary lesions on 68 Ga-PSMA PET/CT was an independent predictor of a favorable pathologic response to NCHT (OR=0.209, 95% CI: 0.102-0.429, P<0.001) [25].…”
Section: Role Of Psma Pet/ct In Nchtmentioning
confidence: 99%
“…Of these patients, 5 patients (6.94%) had pCR and 19 patients (26.39%) had MRD after NCHT. Furthermore, multivariate logistic analysis revealed that the post-NCHT maximum standardized uptake value (SUVmax) of the primary lesions on 68 Ga-PSMA PET/CT was an independent predictor of a favorable pathologic response to NCHT (OR=0.209, 95% CI: 0.102-0.429, P<0.001) [25].…”
Section: Role Of Psma Pet/ct In Nchtmentioning
confidence: 99%